依拉地平(Isradipine, Prescal, Dynadrc, Isr)是瑞士山道士公司1984年开发的新型二氢吡啶类钙拮抗剂,化学名称为异丙基-甲基(士)-4-(4-苯骈呋咱基)-1,4-二-氢-2,6-二甲基-3,5-吡啶二羧酸酯。英国汽巴—嘉基公司1989年2月首次投放英国市场,近年来美国、日本亦批量生产。经临床应用,取得令人鼓舞的效果,日益受到重视。本文就该药的药理作用及临床应用作一综述。 Isradipine (Prescade, Dynadrc, Isr) is a novel dihydropyridine calcium antagonist developed by the Swiss mountain prodigy company in 1984. Its chemical name is isopropyl-methyl-4- Furazanyl) -1,4-di-hydro-2,6-dimethyl-3,5-pyridinedicarboxylate. British Ciba - Jia Ji company in February 1989 for the first time put the British market, in recent years the United States, Japan also mass production. The clinical application has achieved encouraging results and is receiving more and more attention. This article reviews the pharmacological effects and clinical application of this medicine.